eprosartan vs ranitidine
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of eprosartan and ranitidine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Eprosartan pharmacokinetics were not affected by concomitant administration of ranitidine. Ranitidine also has no effect on eprosartan pharmacokinetics.
Teveten
Zantac
Eprosartan (Teveten) is a medicine that lowers high blood pressure. It can be used alone or with other blood pressure medicines.
Ranitidine (Zantac) helps reduce stomach acid. It can relieve heartburn and sour stomach.
Eprosartan is used to treat high blood pressure (hypertension). It can be used by itself or with other medicines to lower your blood pressure. Lowering blood pressure helps prevent strokes, heart attacks, and kidney problems.
This medicine treats heartburn caused by acid indigestion and sour stomach. You can also take it to prevent heartburn. It can prevent heartburn caused by eating or drinking certain foods and drinks.
Eprosartan belongs to a class of drugs called angiotensin II receptor blockers (ARBs). It works by blocking a substance in your body that tightens blood vessels. This helps blood vessels relax, which lowers blood pressure.
Ranitidine is an H2 receptor antagonist. It works by blocking histamine. Blocking histamine reduces the amount of acid your stomach makes.
- • Viral infection
- • Injury
- • Fatigue
- • Abdominal pain
- • Joint pain
- • Headache
No adverse event reports.
- Breast Cancer 24,853
- Prostate Cancer 22,252
- Colorectal Cancer 17,674
- Bladder Cancer 16,746
- Renal Cancer 16,278
If you become pregnant, stop taking eprosartan right away. This medicine can cause serious harm or death to your unborn baby.
No specific warnings noted.
Eprosartan can harm your unborn baby, even causing death. Stop taking this medicine as soon as you know you are pregnant. It is not known if eprosartan passes into breast milk, so talk to your doctor about the best way to feed your baby if you are taking this medicine.
No pregnancy information available.
Also Compare, Nearby Drugs
Compare eprosartan with
Compare ranitidine with
How to Read This eprosartan vs ranitidine Comparison
eprosartan is classified in the Angiotensin II Receptor Blocker (ARB) drug class, while ranitidine sits within the H2 Receptor Antagonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, eprosartan has 0 submissions while ranitidine has 97,803. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to these drugs do not interfere with each other or change how the body handles them.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for eprosartan or ranitidine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.